Histologic changes in Paget's disease treated with calcitonin.
In recent years the use of calcitonin in the medical treatment of Paget's disease of bone has been gaining in popularity. Seventeen patients on long term calcitonin therapy showed objective morphologic evidence of improvement in the quality of bone matrix deposition, in the trabecular organization, and in the parameters used to evaluate the rates of bone turnover. The usefulness of bone biopsy and fine detail radiography of the biopsy core in evaluating the progress of disease and the effects of therapy is discussed. It is concluded that the longer the period of therapy and follow-up, the higher the proportion of patients showing histologic evidence of improvement.
D000368:Aged; D000469:Alkaline Phosphatase / Q000032:analysis; D001706:Biopsy; D001857:Bone Matrix / Q000473:pathology; D001842:Bone and Bones / Q000473:pathology; D002116:Calcitonin / Q000627:therapeutic use*; D002452:Cell Count; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D010010:Osteoclasts / Q000473:pathology; D011859:Radiography
D002116:Calcitonin; D000469:Alkaline Phosphatase